Acorda Therapeutics
ACOR
#11268
Rank
A$1.23 M
Marketcap
A$0.99
Share price
0.00%
Change (1 day)
-95.75%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2024 (TTM): A-$76.45

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$75.50. In 2022 the company made an earnings per share (EPS) of A-$129.62 an increase over its 2021 EPS that were of A-$299.52.

EPS history for Acorda Therapeutics from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$76.45
2022A-$129.62-56.72%
2021A-$299.52-16.13%
2020A-$357.14-65.51%
2019A-$1,035-898.61%
2018A$129.65-114.88%
2017A-$871.55536.84%
2016A-$136.85-392.31%
2015A$46.82-39.53%
2014A$77.434.88%
2013A$73.83-89.54%
2012A$705.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
A-$3.95-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A-$0.30-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
A-$7.84-89.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
A-$0.14-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA